• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

针对人碳酸酐酶 II 的验证命中化合物库的概念验证片段筛选。

A Proof-of-Concept Fragment Screening of a Hit-Validated 96-Compounds Library against Human Carbonic Anhydrase II.

机构信息

Institute for Pharmaceutical Chemistry, Philipps-Universität Marburg, Marbacher Weg 6, 35037 Marburg, Germany.

出版信息

Biomolecules. 2020 Mar 29;10(4):518. doi: 10.3390/biom10040518.

DOI:10.3390/biom10040518
PMID:32235320
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7226012/
Abstract

Fragment screening is a powerful tool to identify and characterize binding pockets in proteins. We herein present the results of a proof-of-concept screening campaign of a versatile 96-entry fragment library from our laboratory against the drug target and model protein human carbonic anhydrase II. The screening revealed a novel chemotype for carbonic anhydrase inhibition, as well as less common non-covalent interaction types and unexpected covalent linkages. Lastly, different runs of the PanDDA tool reveal a practical hint for its application.

摘要

片段筛选是一种强大的工具,可用于鉴定和描述蛋白质中的结合口袋。本文介绍了我们实验室针对药物靶标和模型蛋白人碳酸酐酶 II 进行的一项有说服力的 96 个片段文库的筛选结果。筛选结果揭示了碳酸酐酶抑制作用的新化学型,以及不太常见的非共价相互作用类型和意想不到的共价键。最后,PanDDA 工具的不同运行揭示了其应用的实际提示。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1f1/7226012/8fd22ffdac06/biomolecules-10-00518-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1f1/7226012/88d78d191718/biomolecules-10-00518-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1f1/7226012/c6f0a9920585/biomolecules-10-00518-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1f1/7226012/7051d24e533d/biomolecules-10-00518-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1f1/7226012/e555c8b59cb4/biomolecules-10-00518-sch001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1f1/7226012/a43fc8c2fe20/biomolecules-10-00518-sch002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1f1/7226012/f991e57419ea/biomolecules-10-00518-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1f1/7226012/cd9b5e14c1b8/biomolecules-10-00518-sch003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1f1/7226012/8fd22ffdac06/biomolecules-10-00518-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1f1/7226012/88d78d191718/biomolecules-10-00518-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1f1/7226012/c6f0a9920585/biomolecules-10-00518-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1f1/7226012/7051d24e533d/biomolecules-10-00518-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1f1/7226012/e555c8b59cb4/biomolecules-10-00518-sch001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1f1/7226012/a43fc8c2fe20/biomolecules-10-00518-sch002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1f1/7226012/f991e57419ea/biomolecules-10-00518-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1f1/7226012/cd9b5e14c1b8/biomolecules-10-00518-sch003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d1f1/7226012/8fd22ffdac06/biomolecules-10-00518-g005.jpg

相似文献

1
A Proof-of-Concept Fragment Screening of a Hit-Validated 96-Compounds Library against Human Carbonic Anhydrase II.针对人碳酸酐酶 II 的验证命中化合物库的概念验证片段筛选。
Biomolecules. 2020 Mar 29;10(4):518. doi: 10.3390/biom10040518.
2
Native State Mass Spectrometry, Surface Plasmon Resonance, and X-ray Crystallography Correlate Strongly as a Fragment Screening Combination.天然状态质谱法、表面等离子体共振和 X 射线晶体学相结合,作为一种片段筛选组合,相关性很强。
J Med Chem. 2016 Mar 10;59(5):2192-204. doi: 10.1021/acs.jmedchem.5b01940. Epub 2016 Feb 29.
3
On-DNA hit validation methodologies for ligands identified from DNA-encoded chemical libraries.基于 DNA 编码化合物库的配体的 DNA 上命中验证方法学。
Biochem Biophys Res Commun. 2020 Dec 3;533(2):235-240. doi: 10.1016/j.bbrc.2020.04.030. Epub 2020 Apr 30.
4
Label-free primary screening and affinity ranking of fragment libraries using parallel analysis of protein panels.使用蛋白质组平行分析对片段文库进行无标记初步筛选和亲和力排序。
J Biomol Screen. 2008 Mar;13(3):202-9. doi: 10.1177/1087057108314651. Epub 2008 Feb 12.
5
Synthesis and Biological Potential Assessment of 2-Substituted Quinazolin-4(3H)-ones as Inhibitors of Phosphodiesterase-I and Carbonic Anhydrase-II.2-取代喹唑啉-4(3H)-酮作为磷酸二酯酶-I和碳酸酐酶-II抑制剂的合成及生物活性评估
Med Chem. 2015;11(4):336-41. doi: 10.2174/1573406410666141203123926.
6
Robust and systematic drug screening method using chemical arrays and the protein library: identification of novel inhibitors of carbonic anhydrase II.使用化学阵列和蛋白质文库的强大且系统的药物筛选方法:碳酸酐酶II新型抑制剂的鉴定。
Biosci Biotechnol Biochem. 2008 Oct;72(10):2739-49. doi: 10.1271/bbb.80383. Epub 2008 Oct 7.
7
Experimental validation of a fragment library for lead discovery using SPR biosensor technology.使用表面等离子体共振(SPR)生物传感器技术进行先导化合物发现的片段文库的实验验证。
J Biomol Screen. 2011 Jan;16(1):15-25. doi: 10.1177/1087057110389038. Epub 2010 Dec 13.
8
Development of drug discovery screening system by molecular interaction kinetics-mass spectrometry.基于分子相互作用动力学-质谱的药物发现筛选系统的开发
Rapid Commun Mass Spectrom. 2018 Apr 30;32(8):665-671. doi: 10.1002/rcm.8083.
9
A versatile polypeptide platform for integrated recognition and reporting: affinity arrays for protein-ligand interaction analysis.用于集成识别和报告的多功能多肽平台:用于蛋白质-配体相互作用分析的亲和阵列
Chemistry. 2004 May 17;10(10):2375-85. doi: 10.1002/chem.200305391.
10
Interaction of carbonic anhydrase isozymes I, II, and IX with some pyridine and phenol hydrazinecarbothioamide derivatives.碳酸酐酶同工酶I、II和IX与某些吡啶和苯酚肼基甲硫酰胺衍生物的相互作用。
Bioorg Med Chem Lett. 2015 Dec 1;25(23):5636-41. doi: 10.1016/j.bmcl.2015.10.021. Epub 2015 Oct 13.

引用本文的文献

1
Exploration of Aromatic Hydrazides as Inhibitors of Human Carbonic Anhydrases.芳香酰肼作为人碳酸酐酶抑制剂的研究
Arch Pharm (Weinheim). 2025 Apr;358(4):e202400963. doi: 10.1002/ardp.202400963.
2
Development of a Crystallographic Screening to Identify Sudan Virus VP40 Ligands.用于鉴定苏丹病毒VP40配体的晶体学筛选方法的开发。
ACS Omega. 2024 Jul 18;9(30):33193-33203. doi: 10.1021/acsomega.4c04829. eCollection 2024 Jul 30.
3
Computational Prediction of the Binding Pose of Metal-Binding Pharmacophores.金属结合药效团结合构象的计算预测

本文引用的文献

1
Conformational Changes in Alkyl Chains Determine the Thermodynamic and Kinetic Binding Profiles of Carbonic Anhydrase Inhibitors.烷基链构象变化决定碳酸酐酶抑制剂的热力学和动力学结合特性。
ACS Chem Biol. 2020 Mar 20;15(3):675-685. doi: 10.1021/acschembio.9b00895. Epub 2020 Feb 19.
2
Fragments as Novel Starting Points for tRNA-Guanine Transglycosylase Inhibitors Found by Alternative Screening Strategies.通过替代筛选策略发现的 tRNA-鸟嘌呤糖基转移酶抑制剂的新型起始片段。
ChemMedChem. 2020 Feb 5;15(3):324-337. doi: 10.1002/cmdc.201900604. Epub 2020 Jan 29.
3
Crystallographic screening using ultra-low-molecular-weight ligands to guide drug design.
ACS Med Chem Lett. 2022 Feb 24;13(3):428-435. doi: 10.1021/acsmedchemlett.1c00584. eCollection 2022 Mar 10.
4
Pre-clustering data sets using cluster4x improves the signal-to-noise ratio of high-throughput crystallography drug-screening analysis.使用 cluster4x 对数据集进行预聚类可以提高高通量晶体学药物筛选分析的信噪比。
Acta Crystallogr D Struct Biol. 2020 Nov 1;76(Pt 11):1134-1144. doi: 10.1107/S2059798320012619. Epub 2020 Oct 16.
5
Application of Fragment-Based Drug Discovery to Versatile Targets.基于片段的药物发现技术在多种靶点中的应用。
Front Mol Biosci. 2020 Aug 5;7:180. doi: 10.3389/fmolb.2020.00180. eCollection 2020.
利用超低分子量配体进行晶体筛选以指导药物设计。
Drug Discov Today. 2019 May;24(5):1081-1086. doi: 10.1016/j.drudis.2019.03.009. Epub 2019 Mar 14.
4
Current perspectives in fragment-based lead discovery (FBLD).基于片段的药物发现(FBLD)的当前观点。
Essays Biochem. 2017 Nov 8;61(5):453-464. doi: 10.1042/EBC20170028.
5
A multi-crystal method for extracting obscured crystallographic states from conventionally uninterpretable electron density.多晶体法从传统上无法解释的电子密度中提取隐藏的晶体状态。
Nat Commun. 2017 Apr 24;8:15123. doi: 10.1038/ncomms15123.
6
A False-Positive Screening Hit in Fragment-Based Lead Discovery: Watch out for the Red Herring.基于片段的药物先导发现中的假阳性筛选命中:小心误导。
Angew Chem Int Ed Engl. 2017 Feb 6;56(7):1908-1913. doi: 10.1002/anie.201609824. Epub 2017 Jan 18.
7
P13, the EMBL macromolecular crystallography beamline at the low-emittance PETRA III ring for high- and low-energy phasing with variable beam focusing.P13,位于低发射度PETRA III环上的欧洲分子生物学实验室大分子晶体学光束线,用于可变光束聚焦的高能和低能相位分析。
J Synchrotron Radiat. 2017 Jan 1;24(Pt 1):323-332. doi: 10.1107/S1600577516016465.
8
Active Site Mapping of an Aspartic Protease by Multiple Fragment Crystal Structures: Versatile Warheads To Address a Catalytic Dyad.通过多个片段晶体结构对天冬氨酸蛋白酶的活性位点作图:多用途弹头解决催化二联体。
J Med Chem. 2016 Nov 10;59(21):9743-9759. doi: 10.1021/acs.jmedchem.6b01195. Epub 2016 Oct 28.
9
Experimental Active-Site Mapping by Fragments: Hot Spots Remote from the Catalytic Center of Endothiapepsin.通过片段进行实验性活性位点定位:远离内硫醇蛋白酶催化中心的热点
J Med Chem. 2016 Aug 25;59(16):7561-75. doi: 10.1021/acs.jmedchem.6b00645. Epub 2016 Aug 12.
10
High-Throughput Crystallography: Reliable and Efficient Identification of Fragment Hits.高通量晶体学:可靠高效的片段命中鉴定。
Structure. 2016 Aug 2;24(8):1398-1409. doi: 10.1016/j.str.2016.06.010. Epub 2016 Jul 21.